Moreover, CRISPR–Cas9-mediated knockout of TdT abolished recognition of the B-ALL cell line NALM-6 (naturally TdTpos and HLA-A2pos) by T1 and T3 cells (Fig. 2e and Extended Data Fig. 1d,e). This evidence concerns the gene DNTT and acute lymphoblastic leukemia.